Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Levin

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Journal of Clinical & Cellular Immunology|July 5, 2016
Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model of Neurodegeneration in Multiple SclerosisJoshua N Douglas, Lidia A Gardner, Hannah E Salapa, et al.
Frontiers in Molecular Biosciences|April 29, 2021
A Comprehensive Analysis of the Role of hnRNP A1 Function and Dysfunction in the Pathogenesis of Neurodegenerative DiseaseJoseph P Clarke, Patricia A Thibault, Hannah E Salapa, et al.
Annals of Neurology|October 18, 2024
RNA Binding Protein Dysfunction Links Smoldering/Slowly Expanding Lesions to Neurodegeneration in Multiple SclerosisMiranda L Messmer, Hannah E Salapa, Bogdan F Popescu, et al.
Frontiers in Medicine|July 18, 2025
Fingolimod synergizes with anti-PD-1 radioimmunotherapy in an experimental multiple sclerosis model through enhanced lymph node retention and CD8<sup>+</sup> T cell depletionConnor Frank, Kevin J H Allen, Wojciech Dawicki, et al.
The Journal of Comparative Neurology|December 25, 2019
Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosisCole D Libner, Hannah E Salapa, Catherine Hutchinson, et al.
Journal of Neuroscience Research|June 16, 2004
Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firingFranck Kalume, Sang Min Lee, Yvette Morcos, et al.
Neuroscience Letters|April 8, 2006
Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological diseaseSang Min Lee, Floyd D Dunnavant, Haeman Jang, et al.
Journal of Neuroimmunology|September 8, 2018
Dysfunctional RNA binding proteins and stress granules in multiple sclerosisHannah E Salapa, Chloe Johnson, Catherine Hutchinson, et al.
Multiple Sclerosis International|July 14, 2021
A Descriptive Correlational Study to Evaluate Three Measures of Assessing Upper Extremity Function in Individuals with Multiple SclerosisAman Saini, Audrey Zucker-Levin, Benjamin McMillan, et al.
Journal of Neuroimmunology|July 25, 2016
Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosisMichael C Levin, Sangmin Lee, Lidia A Gardner, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Journal of Clinical & Cellular Immunology|July 5, 2016
Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model of Neurodegeneration in Multiple SclerosisJoshua N Douglas, Lidia A Gardner, Hannah E Salapa, et al.
Frontiers in Molecular Biosciences|April 29, 2021
A Comprehensive Analysis of the Role of hnRNP A1 Function and Dysfunction in the Pathogenesis of Neurodegenerative DiseaseJoseph P Clarke, Patricia A Thibault, Hannah E Salapa, et al.
Annals of Neurology|October 18, 2024
RNA Binding Protein Dysfunction Links Smoldering/Slowly Expanding Lesions to Neurodegeneration in Multiple SclerosisMiranda L Messmer, Hannah E Salapa, Bogdan F Popescu, et al.
Frontiers in Medicine|July 18, 2025
Fingolimod synergizes with anti-PD-1 radioimmunotherapy in an experimental multiple sclerosis model through enhanced lymph node retention and CD8<sup>+</sup> T cell depletionConnor Frank, Kevin J H Allen, Wojciech Dawicki, et al.
The Journal of Comparative Neurology|December 25, 2019
Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosisCole D Libner, Hannah E Salapa, Catherine Hutchinson, et al.
Journal of Neuroscience Research|June 16, 2004
Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firingFranck Kalume, Sang Min Lee, Yvette Morcos, et al.
Neuroscience Letters|April 8, 2006
Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological diseaseSang Min Lee, Floyd D Dunnavant, Haeman Jang, et al.
Journal of Neuroimmunology|September 8, 2018
Dysfunctional RNA binding proteins and stress granules in multiple sclerosisHannah E Salapa, Chloe Johnson, Catherine Hutchinson, et al.
Multiple Sclerosis International|July 14, 2021
A Descriptive Correlational Study to Evaluate Three Measures of Assessing Upper Extremity Function in Individuals with Multiple SclerosisAman Saini, Audrey Zucker-Levin, Benjamin McMillan, et al.
Journal of Neuroimmunology|July 25, 2016
Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosisMichael C Levin, Sangmin Lee, Lidia A Gardner, et al.
Pageof 7